The largest database of trusted experimental protocols

3 protocols using alexa fluor 647 conjugated anti rat igg

1

Evaluating 800CW-aPD-L1 Binding to PD-L1

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate whether 800CW labeling affected the capability of aPD-L1 binding to PD-L1, GL261 cells (which had high surface PD-L1 expression [20 (link)]) were used to perform a binding assay with 800CW-aPD-L1 using flow cytometry. Briefly, GL261 cells (cell count: ~2 × 105) were collected and suspended with 100 μL FACS buffer (0.5% BSA + 2 mM EDTA/PBS). Cells were stained with 1 µg aPD-L1 and 800CW-aPD-L1 at 4 °C for 30 min. Cells without aPD-L1 staining were used as control. After that, all cells were then incubated with 1 µg Alexa Fluor® 647 conjugated anti-rat IgG (Cell Signaling Technology, Beverly, MA, USA) at 4 °C for 30 min. After incubation, cells were washed and resuspended with FACS buffer for measurement with flow cytometry. Data were acquired using MACSQuant (Miltenyi Biotec, Surrey, UK) and analyzed using Flowjo software (Treestar Inc., Ashland, OR, USA).
+ Open protocol
+ Expand
2

Heterogeneous CTC Culture and Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
4T1 cells (murine metastatic breast cancer cell line), tumor-derived endothelial cells and mammary fibroblasts in the ratio of 1:3:2, respectively, were co-cultured in ultra-low attachment U bottom 96-well plates up to 48 h to develop heterogenous CTCs. The clusters were collected using 100 μL of micropipette for further assays. Presence of CTC specific markers such as E-cadherin, CD44 and CK19 were confirmed in the heterogenous CTCs through immunostaining technique. Rat anti-CD44 mAb and rabbit anti E-cadherin (Novus Biologicals, USA) antibody tagged with Alexafluor-647 conjugated anti-rat IgG (Cell Signaling Technology, USA) and Alexafluor-488 anti-rabbit IgG antibody (Molecular Probes, India). Images were taken using laser scanning confocal microscopy (FV1000, Olympus, USA). In the subsequent experiments, clusters were transferred to fresh plates and dosed with nanotheranostic particle suspension (Dox equivalent in 25 μg/mL) for 24 h before analysis. For hyperthermia treated groups, clusters were transferred to eppendorfs and subjected to hyperthermia at 480 kHz for 5 min and stained with specific dyes and antibodies for assays.
+ Open protocol
+ Expand
3

Isolation and Characterization of Bruceine D

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bruceine D was isolated from the fruits of Brucea javanica (Linn.) Merr in our laboratory16 . For in vitro experiment, BD was dissolved in 100% DMSO (Sigma, 01934-1L) at a final stock concentration of 50 mmol/L and stored at −20 °C as single used aliquot. The antibodies for GAPDH (5174s, 1:1000), β-actin (3700s, 1:1000), HIF-1α (36169s, 1:1000), β-catenin (8480s, 1:1000), PKM2 (4053T, 1:1000), HK2 (2867T, 1:1000), LDHA (3582T, 1:1000), Cyt c (11940T, 1:1000), HRP-conjugated anti-rabbit IgG (1:5000), HRP-conjugated anti-mouse IgG (1:5000), and Alexa Fluor 647 conjugated-anti-rat IgG (4418s, 1:1000) were purchased from Cell signaling technology (CST, Danvers, MA, USA). Primary antibodies for GLUT1 (ab115730, 1:1000), GLUT3 (ab191071,1:1000), HIF-1β (ab239366, 1:1000), ICAT (ab129011, 1:1000), HIF-1α (ab51608, 1:1000), and recombinant ICAT (ab101468) were both obtained from Abcam (Cambridge, UK). MCT4 (sc-376140, 1:1000) mouse IgG (sc-2025, 1:50) was procured from Santa Cruz (OR, USA). Recombinant human ICAT protein (ab101468) was obtained from Abcam (Cambridge, UK). Cycloheximide (Sigma, 5087390001) and MG132 (Sigma, SML1135) was obtained from Sigma (Shanghai, China).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!